Subsequently, based on the TGCA results, NOD/SCID mouse xenografts of both human glioma and lung adenocarcinoma were used to detect the nuclear protein domain specificity of KLHL14 and E-Cad antibodies (see Figure S1 Supplement). This evidence concerns the gene CDH1 and central nervous system cancer.